2010Modern Practical MedicineRequires access

The Changes of proton magnetic resonance spectroscopy (1H-MRS) in substantia nigra and corpus striatum in the patients with Parkinson's disease

HE Jinca

Open publisher page 0 citations

Abstract

Objective To investigate the changes of proton magnetic resonance spectroscopy(MRS)inthe substantia nigra, thalamus and corpus striatum in patients with Parkinsonp's disease (PD); and to evaluate the clinical value of the technique on the pathophysiological process and the diagnose of PD. Methods The content of NAA, Cho and Cr in substantia nigra, thalamus and corpus striatum in 50 patients and 45 age-matched healthy controls were examined with proton MRS. The ratios of NAA/Cr, Cho/Cr and NAA/Cho were calculated. Results The ratio of NAA/ Cr in the substantia nigra in PD patients showed significant reduction compared to the controls. However, no significant differences were found in other ratios in these two areas. Conclusion The reduction of NAA/Cr ratio in substantia nigra in PD patients may indicate the dysfunction of the neurons. Proton MRS may be used as a noninvasive way to diagnose PD and to understand the pathophysiological process of PD.

About this research paper

What this paper is about

Objective To investigate the changes of proton magnetic resonance spectroscopy(MRS)inthe substantia nigra, thalamus and corpus striatum in patients with Parkinsonp's disease (PD); and to evaluate the clinical value of the technique on the pathophysiological process and the diagnose of PD. Methods The content of NAA, Cho and Cr in substantia nigra, thalamus and corpus striatum in 50 patients and 45 age-matched healthy controls were examined with proton MRS. The ratios of NAA/Cr, Cho/Cr and NAA/Cho were calculated. Results The ratio of NAA/ Cr in the substantia nigra in PD patients showed significant reduction compared to the controls. However, no significant differences were found in other ratios in these two areas. Conclusion The reduction of NAA/Cr ratio in substantia nigra in PD patients may indicate the dysfunction of the neurons. Proton MRS may be used as a noninvasive way to diagnose PD and to understand the pathophysiological process of PD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the changes of proton magnetic resonance spectroscopy(MRS)inthe substantia nigra, thalamus and corpus striatum in patients with Parkinsonp's disease (PD); and to evaluate the clinical value of the technique on the pathophysiological process and the diagnose of PD. Methods The content of NAA, Cho and Cr in substantia nigra, thalamus and corpus striatum in 50 patients and 45 age-matched healthy controls were examined with proton MRS. The ratios of NAA/Cr, Cho/Cr and NAA/Cho were calculated. Results The ratio of NAA/ Cr in the substantia nigra in PD patients showed significant reduction compared to the controls. However, no significant differences were found in other ratios in these two areas. Conclusion The reduction of NAA/Cr ratio in substantia nigra in PD patients may indicate the dysfunction of the neurons. Proton MRS may be used as a noninvasive way to diagnose PD and to understand the pathophysiological process of PD.

Key concepts: Substantia nigra, Striatum, Putamen, Proton magnetic resonance, Parkinson's disease, Pathophysiology, Thalamus, Chemistry

Related papers

Back to paper searchBrowse research topicsOriginal source
The Changes of proton magnetic resonance spectroscopy (1H-MRS) in substantia nigra and corpus striatum in the patients with Parkinson's disease — Research Paper | ScholarLens